Amid efforts to care for the large number of patients with coronavirus disease (COVID-19),
there has been considerable speculation about whether the lung injury seen in these …

Acute respiratory distress syndrome (ARDS) is a common and life-threatening cause of
respiratory failure. Despite decades of research, there are no effective pharmacologic …

Background: Right ventricular (RV) dysfunction is common and associated with worse
outcomes in patients with coronavirus disease 2019 (COVID-19). In non-COVID-19 acute …

Clinical and molecular heterogeneity are common features of human disease.
Understanding the basis for heterogeneity has led to major advances in therapy for many …

Background Pulmonary hypertension (PH) is frequently observed in patients with acute
respiratory distress syndrome (ARDS) and it is associated with an increased risk of mortality …

Aims Pulmonary hypertension (PH) has been consistently associated with adverse
outcomes in hospitalized patients. Limited epidemiologic data exist regarding PH in the …

Background Pulmonary vascular dysfunction has been described in patients with acute
respiratory distress syndrome (ARDS). Veno‐venous extracorporeal membrane oxygenation …

Acute respiratory distress syndrome (ARDS) is one of the most common severe diseases
seen in the clinical setting. With the continuous exploration of ARDS in recent decades, the …

Various cardiovascular complications have been reported in patients with coronavirus
disease 2019. Common complications include acute myocardial injury, myocarditis …

Background: COPD is the third leading cause of death worldwide, and is often complicated
by exacerbations, infections, and cardiovascular complications, which frequently result in …